{
    "organizations": [],
    "uuid": "9cae5efece0dccac87fe0c086955433dbe1bdcbb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gw-pharma-announces-unanimous-posi/brief-gw-pharma-announces-unanimous-positive-result-of-fda-advisory-committee-meeting-idUSFWN1RW0V3",
    "ord_in_thread": 0,
    "title": "BRIEF-GW Pharma Announces Unanimous Positive Result Of FDA Advisory Committee Meeting",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - GW Pharmaceuticals PLC:\n* GW PHARMACEUTICALS AND U.S. SUBSIDIARY GREENWICH BIOSCIENCES ANNOUNCES THE UNANIMOUS POSITIVE RESULT OF FDA ADVISORY COMMITTEE MEETING FOR FIRST PLANT-BASED PHARMACEUTICAL CANNABIDIOL TREATMENT FOR SEIZURES IN PATIENTS WITH TWO RARE, SEVERE FORMS OF EPILEPSY\n* GW PHARMACEUTICALS PLC - EPIDIOLEX WAS GENERALLY WELL TOLERATED WITH MOST ADVERSE EVENTS REPORTED AS MILD OR MODERATE\n* GW PHARMACEUTICALS PLC - PDUFA GOAL DATE FOR COMPLETION OF NDA REVIEW OF THE CANNABIDIOL ORAL SOLUTION EPIDIOLEX IS JUNE 27, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-20T01:37:00.000+03:00",
    "crawled": "2018-04-20T11:27:08.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "gw",
        "pharmaceutical",
        "plc",
        "gw",
        "pharmaceutical",
        "subsidiary",
        "greenwich",
        "bioscience",
        "announces",
        "unanimous",
        "positive",
        "result",
        "fda",
        "advisory",
        "committee",
        "meeting",
        "first",
        "pharmaceutical",
        "cannabidiol",
        "treatment",
        "seizure",
        "patient",
        "two",
        "rare",
        "severe",
        "form",
        "epilepsy",
        "gw",
        "pharmaceutical",
        "plc",
        "epidiolex",
        "generally",
        "well",
        "tolerated",
        "adverse",
        "event",
        "reported",
        "mild",
        "moderate",
        "gw",
        "pharmaceutical",
        "plc",
        "pdufa",
        "goal",
        "date",
        "completion",
        "nda",
        "review",
        "cannabidiol",
        "oral",
        "solution",
        "epidiolex",
        "june",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}